Further description of early clinically silent lupus nephritis

Lupus

Volumn 15, Issue 12, 2006, Pages 845-851

  Zabaleta Lanz, Mercedes E ^a,b   Munoz L E ^a   Tapanes, F J ^a   Vargas Arenas, R E ^a   Daboin, I ^a   Barrios, Y ^a   Pinto, J A ^a   Bianco, N E ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Instituto de Inmunologia   (United States)

Author keywords

Anti C1q autoantibodies; Overt lupus nephritis; Silent lupus nephritis; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; DOUBLE STRANDED DNA ANTIBODY; FIBRINOGEN; HISTONE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBONUCLEOPROTEIN ANTIBODY;

ADULT; ALPHA CHAIN; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; HUMAN; KIDNEY FUNCTION TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; BIOPSY; COMPLEMENT C1Q; COMPLEMENT C3; DNA; EARLY DIAGNOSIS; FEMALE; FIBRINOGEN; HUMANS; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 33846012881     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306070002     Document Type: Article

References (45)

1. Cruchaud A, Chenais F, Fournie GJ et al. Immunecomplex deposits in systemic lupus erythematosus kidney without histological or functional alterations. Eur J Clin Invest 1975; 5: 297-309.
2. Hollcraft RM, Dubois EL, Lundberg GD et al. Renal damage in systemic lupus erythematosus with normal renal function. J Rheumatol 1976; 3: 251-261.
3. Mahajan SK, Ordoñez NG, Freitelson PJ, Lim VS, Spargo BH, Katz AL. Lupus nephropathy without clinical renal involvement. Medicine (Baltimore) 1977; 56: 493-501.
4. Cavallo T, Cameron WR, Lapenas D. Immunopathology of early and clinically silent lupus nephropathy. Am J Pathol 1977; 87; 1-18.
5. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus in the 1980s. A survey of 570 patients. Semin Arthritis Rheum 1991; 21: 55-64.
6. Wolf A, Croker B, Osofsky SG, Kredich DW. Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment. Pediatrics 1979; 64: 678-685.
7. Bennet WM, Bardana EJ, Norman DJ, Houghton DC. Natural history of "silent" lupus nephritis. Am J Kidney Dis 1982; 1: 359-363.
8. Roujeau JC, Belghiti D, Hirbee G et al. Silent lupus nephritis among patients with discoid lupus erythematosus. AcM Derm Venereal 1984; 64: 160-163.
9. Stamenkovic I, Favre H, Donath A, Assimacopoulos A, Chatelanat F. Renal biopsy in systemic lupus erythematosus irrespective of clinical findings: Long-term follow-up. Clin Nephrol 1986; 26: 109-115.
10. Font J, Torras A, Cervera R, Darnell A, Revert L, Ingelmo M. Silent renal disease in systemic lupus erythematosus. Clin Nephrol 1987; 27: 283-288.
11. Miyata M. Clinical and pathological study of lupus nephritis without clinical renal involvement. Nippon Ginzo Gakkai Shi 1993; 35: 1051-1058.
12. Gonzalez-Crespo MR, López-Fernández JL, Usera G, Poveda MJ, Gomez-Reino J. Outcome of silent lupus nephritis. Sem Arthritis Rheum 1996; 26: 468-476.
13. Zabaleta-Lanz M, Vargas-Arenas RE, Tápanes F, Daboin I, Pinto JA, Bianco NE. Silent nephritis in systemic lupus erythematosus. Lupus 2003; 12: 26-30.
14. Weening JJ, D'Agati VD, Schwartz MM et al. On behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the classification of lupus nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
15. Churg J, Sobin LH. Lupus nephritis in renal diseases. Classification and atlas of glomerular disease. Igaku-Shoin, 1982: 127-131.
16. Churg J, Bernstein J, Glassock RJ. Renal disease: classification and atlas of glomerular disease, second edition. Igaku-Shoin, 1995: 151-156.
17. Hochberg MC. Updating the American College of Rheumatology criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
18. Bombardier C, Gladman D, Urowitz M, and The Committe on Prognosis in SLE. Derivation of SLEDAI a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
19. Kent J, Fife E. Precise standarization of reagents in complement assays. Am J Trop Med Hyg 1963; 12: 103-106.
20. Orozco A, Sánchez P, Bianco NE et al. Solid phase C1q microassay for the rapid detection of circulating immunocomplexes. Immunol Meth 1983; 59: 237-243.
21. Schwartz MM. The pathologic diagnosis of renal diseases. In Heptinstall's pathology of the kidney. Jennette JCh, Olson JL, Schwartz MM, Silva FG eds. Lippincott-Raven Pub, 1998: 169-180.
22. Austin III HA, Muenz LR, Joyce KM et al. Diffuse proliferative lupus nepritis: Identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689-685.
23. Siegert C, Daha M, Westedt M, Van der Voort E, Breeveld F, Coremans I. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991; 18: 230-234.
24. Mittal B, Rennke H, Singh AK. The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens 2005; 14: 1-8.
25. Gunnarson I, Ronnelid J, Huang Y et al. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patient with active systemic lupus erythematosus. Br J Rheum 1998; 36: 32-37.
26. Moroni G, Trendelenburg M, Del Papa N et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001; 31: 490-498.
27. Seelen M, Trouw L, Daha M. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr Op Nephrol Hypertens 2003; 12: 619-624.
28. Siegert C, Daha M, Tseng C, Coremans I, Van Es LA, Breedveld FC. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993; 52: 851-856.
29. Marto N, Bertolaccini ML, Calabuig E, Hughes GRV, Khamashta MA. Anti C1q antibodies in nephritis: Correletion between titres and renal diseases activity and positive valves in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 444-448.
30. Zabaleta-Lanz ME, Muñoz LE, Vargas-Arenas RE, Tapanes FJ, Bianco NE. AntiC1q, antihistone antibodies and C1q deposits in silent lupus nephritis. Clin Immunol 2005; S105 (abstract Sa1.54).
31. Trouw LA, Groene veld TWL, Seelen MA et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q containing immune complexes. J Clin Invest 2004; 114: 679-688.
32. Trouw LA, Duys JMGJ, van Kooten, Daha MR. Immune deposition of C1q and anti-C1q in the kidney is dependent on the presence of glomerular IgG. Mol Immunol 2003; 40: 595-602.
33. Escalante A, Brey RL, Mitchell BDJ et al. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic erythematosus. Am J Med 1995; 98: 559-565.
34. Abu-Shakra M, Urowitz MB, Gladman DD et al. The significance of cardiolipin antibodies in patients with lupus nephritis. Lupus 1996; 5: 70-73.
35. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344.
36. Schur PH, Sandson J. Immunological factors and clinical activity in lupus erythematosus. N Engl J Med 1968; 278: 533-538.
37. Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M. Anti-ribosomal P antibodies in systemic lupus erytematosus: A case control study correlating hepatic and renal diseases. Clin Immunol Immunopathol 1995; 74: 252-256.
38. Maddison PJ, Reichlin M. Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arthritis Rheum 1979; 22: 858-863.
39. Kohda S, Kanayama Y, Okamura M et al. Clinical significance of antibodies to histones in systemic lupus erythematosus. J Rheumathol 1989; 16: 24-28.
40. Chabre H, Amoura Z, Piette JC et al. Presences of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995; 38: 1485-1491.
41. Reichlin M. Serological correlations with nephritis in systemic lupus erythematosus. Clin Immunol 2003; 117: 12-14.
42. Cortés-Hernandez J, Ordi-Ros J, Labrados M et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 2004; 116: 165-173.
43. Mok CC, Tang SSK. Incidence and predictors of renal diseases in chinese patients with systemic lupus erythematosus. Am J Med 2004; 117: 791-795.
44. Tápanes FJ, Vásquez M, Ramírez R, Matheus C, Rodríguez MA, Bianco NE. Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable antinuclear antibodies protective? Lupus 2000; 9: 437-444.
45. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005; 52: 4003-4010.